IGF for the treatment of Rett Syndrome and synaptic disorders

Details for Australian Patent Application No. 2008262387 (hide)

Owner Whitehead Institute for Biomedical Research Massachusetts Institute of Technology

Inventors Giacometti, Emanuela; Tropea, Daniela; Wilson, Nathan R.; Sur, Mriganka; Jaenisch, Rudolf

Agent Shelston IP

Pub. Number AU-A-2008262387

PCT Pub. Number WO2008/153929

Priority 60/933,738 08.06.07 US

Filing date 6 June 2008

Wipo publication date 18 December 2008

International Classifications

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/153929 Priority application(s): WO2008/153929

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262388-Sensors for the detection of diols and carbohydrates using boronic acid chelators for glucose

2008262384-Inhibitors of receptor tyrosine kinases and methods of use thereof